Abiopharma

🔍 Mougis Steven John (Executive)

Company: DoubleVerify Holdings, Inc. (DV)

Report Date: 2026-06-15

Detailed Transactions and Holdings:

• Acquired 9,376 shares of Common Stock (Direct)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 77,520.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 4,474 shares of Common Stock at $10.25 per share (Direct)
  Date: 2026-06-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 73,046.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 842 shares of Common Stock (Direct)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 73,888.00 | transaction_form_type: 4 | Footnotes: F3
• Sold 304 shares of Common Stock at $10.25 per share (Direct)
  Date: 2026-06-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 73,584.00 | transaction_form_type: 4 | Footnotes: F4
• Acquired 3,171 shares of Common Stock (Direct)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 76,755.00 | transaction_form_type: 4 | Footnotes: F5
• Sold 1,144 shares of Common Stock at $10.25 per share (Direct)
  Date: 2026-06-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 75,611.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 27,056 shares of Common Stock (Direct)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 102,667.00 | transaction_form_type: 4 | Footnotes: F6
• Sold 9,754 shares of Common Stock at $10.25 per share (Direct)
  Date: 2026-06-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 92,913.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 250 shares of Common Stock (Direct)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 93,163.00 | transaction_form_type: 4 | Footnotes: F7
• Sold 91 shares of Common Stock at $10.25 per share (Direct)
  Date: 2026-06-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 93,072.00 | transaction_form_type: 4 | Footnotes: F4
• Acquired 2,125 shares of Common Stock (Direct)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 95,197.00 | transaction_form_type: 4 | Footnotes: F8
• Sold 767 shares of Common Stock at $10.25 per share (Direct)
  Date: 2026-06-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 94,430.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 1,143 shares of Common Stock (Direct)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 95,573.00 | transaction_form_type: 4 | Footnotes: F9
• Sold 413 shares of Common Stock at $10.25 per share (Direct)
  Date: 2026-06-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 95,160.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 9,376 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 93,748.00 | transaction_form_type: 4 | Footnotes: F10, F1, F1
• Sold 842 shares of Performance Stock Units (Derivative)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 5,049.00 | transaction_form_type: 4 | Footnotes: F11, F3, F3
• Sold 3,171 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 34,876.00 | transaction_form_type: 4 | Footnotes: F10, F5, F5
• Sold 27,056 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 81,168.00 | transaction_form_type: 4 | Footnotes: F10, F6, F6
• Sold 250 shares of Performance Stock Units (Derivative)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 502.00 | transaction_form_type: 4 | Footnotes: F11, F7, F7
• Sold 2,125 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 14,873.00 | transaction_form_type: 4 | Footnotes: F10, F8, F8
• Sold 1,143 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 3,429.00 | transaction_form_type: 4 | Footnotes: F10, F9, F9

Footnotes:

• F1: Each restricted stock unit was granted on March 12, 2026. 8.33% of the restricted stock units vested and were settled on March 15, 2026 (the "2026 Vesting Date"), and the remainder of the restricted stock units vest and settle at a rate of 8.33% on each quarterly anniversary of the 2026 Vesting Date.
• F2: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
• F3: Each performance stock unit was granted on March 31, 2025. 41.67% of the earned shares vested and were settled on the 2026 Vesting Date, and the remainder of the earned shares vest and settle at a rate of 8.33% on each quarterly anniversary of the 2026 Vesting Date.
• F4: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of performance stock units.
• F5: Each restricted stock unit was granted on March 31, 2025. 6.25% of the restricted stock units vested and settled on June 15, 2025 (the "2025 Vesting Date"), and the remainder of the restricted stock units vest and settle at a rate of 6.25% on each quarterly anniversary of the 2025 Vesting Date.
• F6: Each restricted stock unit was granted on March 13, 2025. 12.5% of the restricted stock units vested and were settled on the 2025 Vesting Date, and the remainder of the restricted stock units vest and settle at a rate of 12.5% on each quarterly anniversary of the 2025 Vesting Date.
• F7: Each performance stock unit was granted on March 15, 2024. 41.67% of the earned shares vested and were settled on March 15, 2025 (the "2025 PSU Vesting Date"), and the remainder of the earned shares vest and settle at a rate of 8.33% on each quarterly anniversary of the 2025 PSU Vesting Date.
• F8: Each restricted stock unit was granted on March 15, 2024. 6.25% of the restricted stock units vested and settled on June 15, 2024 (the "2024 Vesting Date"), and the remainder of the restricted stock units vest and settle at a rate of 6.25% on each quarterly anniversary of the 2024 Vesting Date.
• F9: Each restricted stock unit was granted on March 15, 2023. 6.25% of the restricted stock units vested and settled on June 15, 2023 (the "2023 Vesting Date") and the remainder of the restricted stock units vest and settle at a rate of 6.25% on each quarterly anniversary of the 2023 Vesting Date.
• F10: Restricted stock units convert into common stock on a one-for-one basis.
• F11: Performance stock units convert into common stock on a one-for-one basis.